Search Orphan Drug Designations and Approvals
-
Generic Name: | Cepharanthine |
---|---|
Date Designated: | 01/14/2021 |
Orphan Designation: | Treatment of Esophageal Cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sairiyo Therapeutics Inc. 77 King Street West, Suite 2905 Toronto, Ontario M5K 1H1 Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-